VivoSim Labs(VIVS)
$0.12-0.00 (-2.44%)
VIVS
VivoSim Labs financials statements
$0.12
At close:-0.00 (-2.44%)
VivoSim Labs (VIVS) Ratios
1,615 Followers
VivoSim Labs Ratios
VIVS's free cash flow for Q2 2027 was $-2.54M. For the 2027 fiscal year, VIVS's free cash flow was decreased by $-62.00K and operating cash flow was $-2.48M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.38 | 2.12 | 4.64 | 21.35 | 53.26 |
| Quick Ratio | 2.38 | 1.96 | 4.64 | 21.35 | 53.26 |
| Cash Ratio | 1.80 | 1.56 | 4.17 | 20.73 | 51.82 |
| Solvency Ratio | -1.61 | -5.24 | -3.40 | -3.66 | -23.28 |
| Operating Cash Flow Ratio | -3.89 | -7.88 | -3.38 | -6.11 | -18.48 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -1.86M | $ 1.19M | $ 12.06M | $ 26.45M | $ 37.68M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.06 | 0.22 | 0.09 | 0.07 | 0.00 |
| Debt-to-Equity Ratio | -0.41 | 0.39 | 0.12 | 0.07 | 0.00 |
| Debt-to-Capital Ratio | -0.69 | 0.28 | 0.11 | 0.07 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -6.72 | 1.76 | 1.33 | 1.10 | 1.02 |
| Debt Service Coverage Ratio | -1112.42 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | -935.33 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.18 | 1.83 | 2.49 | 3.01 | 0.00 |
| Net Debt to EBITDA | 0.34 | 0.10 | 0.77 | 2.34 | 2.23 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| EBIT Margin | -10355.73% | -13840.37% | -4792.16% | -765.27% | 0.00% |
| EBITDA Margin | -10191.60% | -13583.49% | -4712.97% | -755.80% | 0.00% |
| Operating Profit Margin | -8567.94% | -13840.37% | -4792.16% | -765.27% | 0.00% |
| Pretax Profit Margin | -10364.89% | -13457.80% | -4664.05% | -763.07% | 0.00% |
| Net Profit Margin | -10567.18% | -13459.63% | -4664.59% | -763.20% | 0.00% |
| Continuous Operations Profit Margin | -10363.36% | -13459.63% | -4664.59% | -763.20% | 0.00% |
| Net Income Per EBT | 101.95% | 100.01% | 100.01% | 100.02% | 100.01% |
| EBT Per EBIT | 120.97% | 97.24% | 97.33% | 99.71% | 99.99% |
| Return on Assets (ROA) | -187.42% | -231.08% | -84.97% | -34.38% | -42.15% |
| Return on Equity (ROE) | 1259.60% | -407.41% | -112.59% | -37.90% | -42.93% |
| Return on Capital Employed (ROCE) | -243.95% | -336.07% | -106.54% | -35.97% | -42.93% |
| Return on Invested Capital (ROIC) | -222.31% | -302.02% | -103.48% | -35.44% | -42.93% |
| Return on Tangible Assets | -187.42% | -231.08% | -84.97% | -34.38% | -42.15% |
| Earnings Yield | -374.00% | -1119.27% | -1381.97% | -917.66% | -1700.82% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.13 | 3.30 | 2.43 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.21 | 0.06 | 0.14 | 0.53 | 0.00 |
| Asset Turnover | 0.02 | 0.02 | 0.02 | 0.05 | 0.00 |
| Working Capital Turnover Ratio | 0.02 | 0.01 | 0.02 | 0.05 | 0.00 |
| Cash Conversion Cycle | 2914.43 | 110.50 | 149.95 | 0.00 | 0.00 |
| Days of Sales Outstanding | 2914.43 | 110.50 | 149.95 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 2914.43 | 110.50 | 149.95 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -4.18 | -19.23 | -17.09 | -11.65 | -23.16 |
| Free Cash Flow Per Share | -4.18 | -19.28 | -17.63 | -12.22 | -23.87 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -348.88 | -31.33 | -20.67 | -32.90 |
| Capital Expenditure Coverage Ratio | 0.00 | -348.88 | -31.33 | -20.67 | -32.90 |
| Operating Cash Flow Coverage Ratio | -24.22 | -10.51 | -6.87 | -3.87 | 0.00 |
| Operating Cash Flow to Sales Ratio | -82.65 | -134.43 | -33.54 | -5.64 | 0.00 |
| Free Cash Flow Yield | -292.52% | -1121.10% | -1025.25% | -710.37% | -1387.67% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.27 | -0.09 | -0.07 | -0.11 | -0.06 |
| Price-to-Sales (P/S) Ratio | 28.25 | 12.03 | 3.38 | 0.83 | 0.00 |
| Price-to-Book (P/B) Ratio | -3.37 | 0.36 | 0.08 | 0.04 | 0.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.34 | -0.09 | -0.10 | -0.14 | -0.07 |
| Price-to-Operating Cash Flow Ratio | -0.34 | -0.09 | -0.10 | -0.15 | -0.07 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.00 | -0.00 | 0.00 | 0.00 |
| Enterprise Value Multiple | 0.07 | 0.01 | 0.70 | 2.23 | 2.17 |
| Enterprise Value | -875.69K | -196.23K | -12.25M | -25.24M | -36.37M |
| EV to EBITDA | 0.07 | 0.01 | 0.70 | 2.23 | 2.17 |
| EV to Sales | -6.68 | -1.80 | -33.10 | -16.83 | 0.00 |
| EV to Free Cash Flow | 0.08 | 0.01 | 0.96 | 2.85 | 2.65 |
| EV to Operating Cash Flow | 0.08 | 0.01 | 0.99 | 2.99 | 2.73 |
| Tangible Book Value Per Share | -0.42 | 4.73 | 21.11 | 41.65 | 68.15 |
| Shareholders’ Equity Per Share | -0.42 | 4.73 | 21.11 | 41.65 | 68.15 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.05 | 0.14 | 0.51 | 2.07 | 0.00 |
| Net Income Per Share | -5.35 | -19.25 | -23.77 | -15.78 | -29.25 |
| Tax Burden | 1.02 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 0.97 | 0.97 | 1.00 | 1.00 |
| Research & Development to Revenue | 31.98 | 50.44 | 24.01 | 2.21 | 0.00 |
| SG&A to Revenue | 54.70 | 88.48 | 24.56 | 6.42 | 0.00 |
| Stock-Based Compensation to Revenue | 2.31 | 13.83 | 6.42 | 1.50 | 0.00 |
| Income Quality | 0.78 | 1.00 | 0.72 | 0.74 | 0.79 |
Currency in USD

